Skip to main content

Advertisement

SpringerLink
Log in

Single perioperative dose of tranexamic acid in primary hip and knee arthroplasty

  • Original Article
  • Published:
European Journal of Orthopaedic Surgery & Traumatology Aims and scope Submit manuscript

Abstract

Introduction

Tranexamic acid (TXA) is an antifibrinolytic agent that competitively inhibits the activation of plasminogen to plasmin. It has been shown to reduce blood loss in trauma and other haemorrhagic conditions and has recently been utilised in elective orthopaedic surgery. There are various methods of administering TXA described in the literature.

Methods

This retrospective cohort study reviews the effects of a single perioperative 1 g intravenous bolus on patients undergoing primary hip and knee arthroplasty and its effect on operative blood loss. After excluding patients who did not fulfil our inclusion criteria, a total of 110 patients were included in this study. Fifty underwent primary hip arthroplasty (30 treated with TXA; 60.0 %), and 60 underwent primary knee arthroplasty (29 treated with TXA; 48.3 %). The main outcome measure was red cell volume and total blood loss, and secondary measures were needed for blood transfusions, presence of thromboembolic events, and length of hospital stay.

Results

Both cohorts who received TXA showed a reduction in immediate postoperative red cell volume loss and total blood loss (p < 0.01). There was no association with the administration of TXA and the rate of postoperative blood transfusions (hip p = 0.36, knee p = 0.13), incidence of symptomatic deep vein thrombosis (hip p = 0.36, knee p = 0.31), or postoperative hospital length of stay (hip p = 0.70, knee p = 0.68).

Conclusion

This study demonstrates that a single perioperative bolus of intravenous TXA may significantly reduce operative blood loss in both primary total hip and knee arthroplasty in a cost-effective manner, in combination with meticulous perioperative haemostasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, (CRASH-2 collaborators) et al (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage: a randomised, placebo-controlled trial. Lancet 376:23–32

    Article  CAS  PubMed  Google Scholar 

  2. Roberts I, Shakur H, Ker K, Coats T, (CRASH-2 collaborators) (2011) Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev 1:CD004896

    PubMed  Google Scholar 

  3. Marti DN, Schaller J, Llinas M (1999) Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains. Biochemistry 38(48):15741–15755

    Article  CAS  PubMed  Google Scholar 

  4. Okamoto S, Hijikata-Okunomiya A, Wanaka K, Okada Y, Okamoto U (1997) Enzyme controlling medicines. Semin Thromb Hemost 23(6):493–501

    Article  CAS  PubMed  Google Scholar 

  5. Sukeik M, Alshryda S, Haddad FS, Mason JM (2001) Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg 93(1):39–46

    Google Scholar 

  6. Henry DA, Carless PA, Moxey AJ et al (2007) Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 4:CD001886

    PubMed  Google Scholar 

  7. Ker K, Edwards P, Perel P, Shakur H, Roberts I (2012) Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 344:e3054

    Article  PubMed Central  PubMed  Google Scholar 

  8. Bradshaw AR, Monoghan J, Campbell D (2012) Oral tranexamic acid reduces blood loss in total knee replacement arthroplasty. Curr Orthop Pract 23(3):209–212

    Article  Google Scholar 

  9. Wong J, Abrishami A, El Beheiry H, Mahomed NN, Davey JR, Gandhi R, Syed KA et al (2010) Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 92(15):2503–2513

    Article  PubMed  Google Scholar 

  10. Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El-Dawlatly A (2008) Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. Spine 33(24):2577–2580

    Article  PubMed  Google Scholar 

  11. Nadler SB, Hidalgo JU, Bloch T (1962) Prediction of blood volume in normal human adults. Surgery 51:224–232

    PubMed  Google Scholar 

  12. March GM, Elfatori S, Beaulé PE (2013) Clinical experience with tranexamic acid during primary total hip arthroplasty. Hip Int 23(1):72–79

    Article  PubMed  Google Scholar 

  13. Yamasaki S, Masuhara K, Fuji T (2004) Tranexamic acid reduces blood loss after cementless total hip arthroplasty—prospective randomized study in 40 cases. Int Orthop 28(2):69–73

    Article  PubMed Central  PubMed  Google Scholar 

  14. Claeys MA, Vermeersch N, Haentjens P (2007) Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg 107:397–401

    CAS  PubMed  Google Scholar 

  15. Ralley FE, Berta D, Binns V, Howard J, Naudie DDR (2010) One Intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res 468(7):1905–1911

    Article  PubMed Central  PubMed  Google Scholar 

  16. MacGillivray RG, Tarabichi SA, Hawari MF, Raoof NT (2011) Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. J Arthroplast 26(1):24–28

    Article  Google Scholar 

  17. Benoni G, Björkman S, Fredin H (1995) Application of pharmacokinetic data from healthy volunteers for the prediction of plasma concentrations of tranexamic acid in surgical patients. Clin Drug Invest 10(5):280–287

    Article  CAS  Google Scholar 

  18. Horrow JC, Van Riper DF, Strong MD, Grunewald KE, Parmet JL (1995) The dose−response relationship of tranexamic acid. Anesthesiology 82(2):383–392

    Article  CAS  PubMed  Google Scholar 

  19. Meda Pharmaceuticals, Cyklokapron Tablets (2013) Summary of product characteristics. Updated 3 June 2013. http://www.medicines.org.uk/. Visited 3 July 2013

  20. Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Gorinbashi S, Ishii S (2001) Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. JBJS Br 83B(5):702–705

    Article  Google Scholar 

  21. Imai N, Dohmae Y, Suda K, Miyasaka D, Ito T, Endo N (2012) Tranexamic acid for reduction of blood loss during total hip arthroplasty. J Arthroplast 27(10):1838–1843

    Article  Google Scholar 

  22. Benoni G, Lethagen S, Nilsson P, Fredin H (2000) Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. Acta Orthop Scand 71(3):250–254

    Article  CAS  PubMed  Google Scholar 

  23. NHS Blood and Transplant (2013) Blood and Components. Price list. 2013/14. http://hospital.blood.co.uk/library/pdf/price_list_2013_14.pdf. Accessed 16 November 2013

  24. BNF (British National Formulary) (2013) Tranexamic acid. BMJ Group/Royal Pharmaceutical Society of Great Britain. BMJ Publishing Group Ltd/RCPCH Publications Ltd, London

    Google Scholar 

  25. Guerriero C, Cairns J, Perel P, Shakur H, Roberts I (2011) Clinical randomization of an antifibrinolytic in significant hemorrhage 2 trial collaborators. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One 6(5):e18987

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Guerriero C, Cairns J, Jayaraman S, Roberts I, Perel P, Shakur H (2010) Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation. Cost Eff Resour Alloc 8:1

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Trauma and Orthopaedics, Barnet Hospital, Wellhouse Lane, Barnet, EN5 3DJ, UK

    D. A. George, K. M. Sarraf & H. Nwaboku

Authors
  1. D. A. George
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. M. Sarraf
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Nwaboku
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. A. George.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

George, D.A., Sarraf, K.M. & Nwaboku, H. Single perioperative dose of tranexamic acid in primary hip and knee arthroplasty. Eur J Orthop Surg Traumatol 25, 129–133 (2015). https://doi.org/10.1007/s00590-014-1457-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00590-014-1457-5

Keywords

Search

Navigation